How Tuberculosis Bacteria Hijack Human Cells to Evade Immune Defenses

A new study has uncovered how Mycobacterium tuberculosis (Mtb) alters cell death processes in human macrophages to survive within the host. Researchers examined three key forms of programmed cell death—apoptosis, necroptosis, and pyroptosis—and found that Mtb exploits these pathways to persist despite immune responses.

The findings highlight how different strains of Mtb vary in their ability to manipulate these mechanisms, potentially explaining differences in disease severity among patients. The research reveals that Mtb triggers a complex signalling cascade involving caspases, receptor-interacting protein kinases (RIPKs), and inflammasomes. These regulators control cell death pathways, which the bacterium manipulates to evade destruction. Early in infection, apoptosis dominates, while necroptosis and pyroptosis become more prominent later, reflecting shifting immune dynamics within TB granulomas.

Mitochondrial function and reactive oxygen species (ROS) also shape macrophage responses, sometimes worsening inflammation. The study further identifies novel regulators, such as long non-coding RNAs and microRNAs, as potential therapeutic targets. Pharmacological modulation of these pathways could enhance host defences while reducing tissue damage.

Different Mtb strains show varying capacities to influence cell death, which may contribute to the diverse clinical outcomes seen in TB patients. The findings provide a clearer picture of how the pathogen evades immune clearance and persists in the body. The study deepens understanding of Mtb’s survival strategies and the host immune response. By targeting specific cell death regulators, researchers suggest new therapeutic approaches could be developed to combat tuberculosis more effectively. These insights may also help explain why some patients experience more severe disease than others.